+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
MALE
ID04221542

Phase 1 Trial Evaluating Safety, Tolerability, and Efficacy of AMG 509 Alone or with Abiraterone or Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Led by Amgen · Updated on 2026-08-21

479

Participants Needed

57

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating AMG 509 in people with metastatic castration-resistant prostate cancer mCRPC to assess its safety, tolerability, how the body processes the drug, and preliminary effectiveness. The study includes participants who have received various prior treatments such as novel hormonal therapies and taxane chemotherapy. This is a Phase 1 trial with multiple parts, including expansion cohorts, some of which are open for enrollment as of July 2025. The trial tests AMG 509 given either as an intravenous IV infusion or subcutaneous SC injection, alone or combined with oral drugs abiraterone acetate or enzalutamide. Different parts of the study focus on different patient groups and dosing strategies, including dose exploration to find the maximum tolerated dose and recommended phase 2 dose. Some parts also examine AMG 509 given in outpatient infusion centers, with specific cohorts enrolled in China to confirm safety and dosing. Participants undergo screening to confirm eligibility, followed by treatment phases where AMG 509 and combinations are administered according to assigned study parts. Throughout the study, safety is monitored by tracking adverse events, vital signs, ECGs, and lab tests over several years. Effectiveness is assessed using tumor response criteria, prostate-specific antigen levels, and imaging studies. The trial includes long-term follow-up to evaluate treatment outcomes and pharmacokinetics over up to three years.

CONDITIONS

Brief Title

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Research Team

A

Amgen Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here